| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 67457-239-01 | 67457-239 | HUMAN PRESCRIPTION DRUG | Octreotide Acetate | octreotide acetate | INJECTION, SOLUTION | INTRAVENOUS; SUBCUTANEOUS | 20110401 | N/A | ANDA | ANDA079198 | Mylan Institutional LLC | OCTREOTIDE ACETATE | 50 ug/mL | 10 SYRINGE in 1 CARTON (67457-239-01) / 1 mL in 1 SYRINGE (67457-239-00) |
| 67457-246-01 | 67457-246 | HUMAN PRESCRIPTION DRUG | Octreotide Acetate | octreotide acetate | INJECTION, SOLUTION | INTRAVENOUS; SUBCUTANEOUS | 20110401 | N/A | ANDA | ANDA079198 | Mylan Institutional LLC | OCTREOTIDE ACETATE | 500 ug/mL | 10 SYRINGE in 1 CARTON (67457-246-01) / 1 mL in 1 SYRINGE (67457-246-00) |
| 67457-245-01 | 67457-245 | HUMAN PRESCRIPTION DRUG | Octreotide Acetate | octreotide acetate | INJECTION, SOLUTION | INTRAVENOUS; SUBCUTANEOUS | 20110401 | N/A | ANDA | ANDA079198 | Mylan Institutional LLC | OCTREOTIDE ACETATE | 100 ug/mL | 10 SYRINGE in 1 CARTON (67457-245-01) / 1 mL in 1 SYRINGE (67457-245-00) |